Terms: = Ovarian cancer AND CREB1, ENSG00000118260, 1385 AND Prognosis
3 results:
1. Multi-Omics Analysis Identifying Key Biomarkers in ovarian cancer.
Li JY; Li CJ; Lin LT; Tsui KH
Cancer Control; 2020; 27(1):1073274820976671. PubMed ID: 33297760
[TBL] [Abstract] [Full Text] [Related]
2. Clinicopathologic Features and Risk Factors for Recurrence of Mucinous Borderline ovarian Tumors: A Retrospective Study With Follow-up of More Than 10 Years.
Sun L; Li N; Song Y; Wang G; Zhao Z; Wu L
Int J Gynecol Cancer; 2018 Nov; 28(9):1643-1649. PubMed ID: 30365456
[TBL] [Abstract] [Full Text] [Related]
3. Characterization of a repressor element and a juxtaposed tissue-restricted activator element located on the distal neu gene promoter.
Suen TC; Goss PE
J Biol Chem; 2000 Mar; 275(9):6600-7. PubMed ID: 10692468
[TBL] [Abstract] [Full Text] [Related]
